GLP-1 Use Linked to Improved Survival and Fewer Complications in patients with Diabetes and Cancer: Study Dr. Shravani Dali12 Jan 2026 11:00 AM ISTResearchers have found in a new study that adults with type 2 diabetes and cancer who used GLP-1 receptor agonists had a lower risk of death compared...
Cipla Emerges as Domestic Contender in Anti-Obesity Market with Yurpeak Susmita Roy10 Jan 2026 10:06 PM ISTNew Delhi: India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 agonist brand...
Zydus Lifesciences Gets CDSCO Panel Nod to Market Semaglutide Injection for Type 2 Diabetes Susmita Roy9 Jan 2026 11:45 PM ISTNew Delhi: Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the...
Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts sheeba farhat9 Jan 2026 11:28 PM ISTBengaluru: Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic,...
Natco Pharma Challenges Novo Nordisk's Wegovy Patent, Reaches Delhi High Court Susmita Roy7 Jan 2026 11:19 PM ISTNew Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the...
Post-Patent Semaglutide Boom: Generics Set for Rs 50,000 Cr Revenue Upside sheeba farhat5 Jan 2026 5:39 PM ISTIn India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM)...
Alkem Secures CDSCO Panel Approval for Synthetic Semaglutide in Obesity Management Susmita Roy2 Jan 2026 5:48 PM ISTNew Delhi: Drug major Alkem Laboratories Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the...
Sun Pharma Gets CDSCO Panel Nod to Market Semaglutide Injection in Weight Loss Indication Susmita Roy1 Jan 2026 5:06 PM ISTNew Delhi: Drug major Sun Pharmaceutical Industries Limited has received a key regulatory clearance from the Subject Expert Committee (SEC)...
Price war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro Ruchika Sharma30 Dec 2025 6:08 PM ISTGlobal drugmakers Novo Nordisk and Eli Lilly have kicked off a price battle in China’s obesity treatment market, cutting prices of their blockbuster...
Cipla Gets CDSCO Panel Nod to Begin Phase III Study of Semaglutide Injection Susmita Roy30 Dec 2025 2:27 PM ISTNew Delhi: Drug major Cipla Limited has received clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
Semaglutide Reduces Hospital Admissions of Obese Patients Beyond Cardiovascular Benefits: JAMA Medha Baranwal26 Dec 2025 11:30 AM ISTAustralia: In a prespecified exploratory analysis of the SELECT randomized clinical trial, participants were found to have a high baseline burden of...
